Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5801–5850 of 75406
The Company has announced that Mike Henschen will succeed Mr. Aydt as Executive Vice President, Refining, effective June 1, 2025.
Bryan Hill, our Chief Financial Officer, notified the Company on April 25, 2025, that he intends to retire on the earlier of February 27, 2026, or 15 days after the Company hires his successor
On April 28, 2025, the board of directors of Oportun Financial Corporation (the “Company”) appointed Raul Vazquez, the Company’s Chief Executive Officer, to the roles of principal financial officer and principal accounting officer, effective immediately.
On April 28, 2025, Avanos Medical, Inc. (the “Company”) and Michael C. Greiner entered into a Separation and Consulting Agreement (the “Separation and Consulting Agreement”).
On April 25, 2025, the Board of Directors of Yunhong Green CTI Ltd. (the “Company”) accepted the resignation of Director Frank Cesario, and appointed its Chief Executive Officer Jana M. Schwan to the role of Director.
On April 25, 2025, the Board of Directors of Yunhong Green CTI Ltd. (the “Company”) accepted the resignation of Director Frank Cesario, and appointed its Chief Executive Officer Jana M. Schwan to the role of Director.
The grant was made in connection with Mr. Gwin’s resignation from the role of Chief Executive Officer on March 7, 2025
On April 25, 2025, the Board of Directors appointed Tiffany Milton as the Company’s Chief Accounting Officer, effective immediately.
Until a Chief Financial Officer is hired to replace Mr. Jordan, Mr. Michael Zuehlke, Vice President of Finance and Corporate Controller of Zomedica Inc. will assume operational responsibility for accounting and finance matters.
Effective April 25, 2025, Scott Jordan resigned from employment as Chief Financial Officer of Zomedica Corp.
On April 27, 2025, Sadot Group Inc. (the “Company”) with deep sadness announced today that Marvin Yeo, age 53, a member of the Company’s Board of Directors and Sustainability Committee, unexpectedly passed away on Sunday, April 27, 2025.
On April 24, 2025, Gary I. Horowitz notified Grindr Inc. (the “Company”), that he does not intend to stand for re-election at the Company’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”).
Effective as of April 24, 2025, which is the expiration of the 10-day period after the filing and mailing of FiEE, Inc. (the “Company”)’s Schedule 14F-1 filed and mailed on April 14, 2025, Hu Bin and Cao Yu were appointed to the Company’s board of directors.
Effective as of April 30, 2025, David Natan and Chan Oi Fat were appointed to the Company’s board of directors.
Effective as of April 30, 2025, David Natan and Chan Oi Fat were appointed to the Company’s board of directors.
Effective as of April 24, 2025, which is the expiration of the 10-day period after the filing and mailing of FiEE, Inc. (the “Company”)’s Schedule 14F-1 filed and mailed on April 14, 2025, Hu Bin and Cao Yu were appointed to the Company’s board of directors.
Mr. Earl H. Devanny, III retired from the Board of Directors effective April 25, 2025, due to the Company's mandatory retirement age.
Additionally, Ms. Elizabeth W. Camp, Mr. Gary P. Fayard, Mr. John D. Johns and Ms. Wendy B. Needham have retired as directors.
Additionally, Ms. Elizabeth W. Camp, Mr. Gary P. Fayard, Mr. John D. Johns and Ms. Wendy B. Needham have retired as directors.
Additionally, Ms. Elizabeth W. Camp, Mr. Gary P. Fayard, Mr. John D. Johns and Ms. Wendy B. Needham have retired as directors.
On April 29, 2025, Genuine Parts Company (the "Company") issued a press release announcing that its shareholders elected Ms. Laurie Schupmann as a new director of the Company.
Additionally, Ms. Elizabeth W. Camp, Mr. Gary P. Fayard, Mr. John D. Johns and Ms. Wendy B. Needham have retired as directors.
Stephen Lovass ceased to serve as segment leader for the Medical and Fluid Solutions Segment of Nordson Corporation
Steven P. Johnson retired from the Globe Life Inc. Board of Directors at the Annual Meeting of Shareholders on April 24, 2025.
Patrick Conway, M.D., currently Chief Executive Officer of Optum Rx, has been appointed to serve as Chief Executive Officer of Optum on the Effective Date.
Heather Cianfrocco, currently Chief Executive Officer of Optum, has been appointed to serve in the enterprise-wide role of Executive Vice President, Governance, Compliance and Information Security of the Company, effective May 6, 2025
On April 28, 2025, Heron Therapeutics, Inc. (the “ Company ”) announced that it appointed Mark Hensley as Chief Operating Officer, effective April 28, 2025
On April 24, 2025, the Board of Directors (the "Board") of Vroom, Inc. (the "Company") appointed Nikul Patel to the Board, effective April 24, 2025.
On April 28, 2025, Mr. William Douglas Jacob resigned from the Board of Directors of Falcon’s Beyond Global, Inc. (the “Company”), effective as of the close of business on April 29, 2025 in order to pursue another opportunity.
Mr. Fahs will assume the role of Executive Chairman.
Under this plan, effective August 1, 2025, Alex Wilkes will succeed Reade Fahs as the Company’s Chief Executive Officer and will be appointed to the Company’s Board.
Additionally, Thomas V. Taylor, Jr., who joined the Board in 2018, will not stand for reelection at the 2025 annual meeting of stockholders (the “Annual Meeting”) and will be departing as a director immediately following the Annual Meeting.
D. Randolph Peeler, the current Chair of the Board, will assume the role of Lead Independent Director.
appointed Charles W. Newton. to the Board, effective on such date, to fill the resulting vacancy and to serve as a Class III director
On April 28, 2025, the Board adopted a resolution nominating Kelly Campbell for election to the Board with a term that expires at the Company’s 2028 annual meeting of stockholders.
Effective as of the 2025 Annual Meeting, Mr. Cavens will be appointed to fill the vacancy resulting from this increase with a term expiring at the Company’s 2027 annual meeting of stockholders.
On April 28, 2025, Alan Spoon notified the Board of Directors (the “Board”) of Match Group, Inc. (the “Company”) of his decision to not stand for re-election following the expiration of his current term, which will expire at the Company’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”).
On April 25, 2025, Virginia Gambale, a member of the board of directors (the “Board”) of Jamf Holding Corp. (the “Company”) and the Audit Committee of the Board, notified the Company of her intention to not stand for re-election at the Company’s upcoming 2025 annual general meeting of shareholders scheduled for June 10, 2025 (the “Annual Meeting”).
In addition, on April 25, 2025, Charles Guan, a member of the Board of the Company, notified the Company of his intention not to stand for re-election at the Annual Meeting.
On April 29, 2025, the Board of Directors (the “Board”) of Exact Sciences Corporation (the “Company”) appointed Leslie Trigg as a Class II member of the Board with a term ending at the Company’s 2026 annual meeting of shareholders.
Ms. Trigg was appointed to fill the vacancy created by the resignation of Kathleen Sebelius (formerly a Class II director) from the Board on April 29, 2025 for her retirement.
On April 26, 2025, R. Keith Woods informed the board of directors (the “Board”) of Rocket Pharmaceuticals, Inc. (the “Company”) that he has accepted a Chief Operating Officer position with a biopharmaceutical company and therefore has decided not to stand for re-election to the Board at the Company’s upcoming 2025 annual meeting (the “2025 Annual Meeting”).
appointed Alan Alperin as a Class I director of the Company, and stockholders of the Company elected Mr. Alperin, effective April 25, 2025
appointed Kym M. Hubbard as a Class II director of the Company, and stockholders of the Company elected Ms. Hubbard, effective April 25, 2025
Effective April 25, 2025, the Board appointed John P. Rau, the Company’s current Executive Vice President, Global Aviation, Land and Marine, as Chief Operating Officer.
Effective April 25, 2025, the Board of Directors (the “Board”) of World Kinect Corporation (the “Company”) appointed Ira M. Birns, the Company’s current Executive Vice President and Chief Financial Officer, as President and Chief Financial Officer.
Effective April 25, 2025, Mr. Kasbar no longer holds the title of President at the Company.
On April 24, 2025, in connection with the IPO, Daniel J. Hoffman, Dr. Kamal Ghaffarian, William Denkin, and Noah G. Levy were appointed to the board of directors of the Company (the “ Board ”).
On April 24, 2025, in connection with the IPO, Daniel J. Hoffman, Dr. Kamal Ghaffarian, William Denkin, and Noah G. Levy were appointed to the board of directors of the Company (the “ Board ”).
On April 24, 2025, in connection with the IPO, Daniel J. Hoffman, Dr. Kamal Ghaffarian, William Denkin, and Noah G. Levy were appointed to the board of directors of the Company (the “ Board ”).
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.